Cargando…

Are Regulations Safe? Reflections From Developing a Digital Cancer Decision-Support Tool

Informatics solutions to early diagnosis of cancer in primary care are increasingly prevalent, but it is not clear whether existing and planned standards and regulations sufficiently address patients' safety nor whether these standards are fit for purpose. We use a patient safety perspective to...

Descripción completa

Detalles Bibliográficos
Autores principales: McInerney, Ciarán D., Scott, Beverly C., Johnson, Owen A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140795/
https://www.ncbi.nlm.nih.gov/pubmed/33797951
http://dx.doi.org/10.1200/CCI.20.00148
_version_ 1783696246450421760
author McInerney, Ciarán D.
Scott, Beverly C.
Johnson, Owen A.
author_facet McInerney, Ciarán D.
Scott, Beverly C.
Johnson, Owen A.
author_sort McInerney, Ciarán D.
collection PubMed
description Informatics solutions to early diagnosis of cancer in primary care are increasingly prevalent, but it is not clear whether existing and planned standards and regulations sufficiently address patients' safety nor whether these standards are fit for purpose. We use a patient safety perspective to reflect on the development of a computerized cancer risk assessment tool embedded within a UK primary care electronic health record system. METHODS: We developed a computerized version of the CAncer Prevention in ExetER studies risk assessment tool, in compliance with the European Union's Medical Device Regulations. The process of building this tool afforded an opportunity to reflect on clinical concerns and whether current regulations for medical devices are fit for purpose. We identified concerns for patient safety and developed nine practical recommendations to mitigate these concerns. RESULTS: We noted that medical device regulations (1) were initially created for hardware devices rather than software, (2) offer one-shot approval rather than supporting iterative innovation and learning, (3) are biased toward loss-transfer approaches that attempt to manage the fallout of harm instead of mitigating hazards becoming harmful, and (4) are biased toward known hazards, despite unknown hazards being an expected consequence of health care as a complex adaptive system. Our nine recommendations focus on embedding less-reductionist and stronger system perspectives into regulations and standards. CONCLUSION: Our intention is to share our experience to support research-led collaborative development of health informatics solutions in cancer. We argue that regulations in the European Union do not sufficiently address the complexity of healthcare information systems with consequences for patient safety. Future standards and regulations should continue to follow a system-based approach to risk, safety, and accident avoidance.
format Online
Article
Text
id pubmed-8140795
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-81407952022-04-02 Are Regulations Safe? Reflections From Developing a Digital Cancer Decision-Support Tool McInerney, Ciarán D. Scott, Beverly C. Johnson, Owen A. JCO Clin Cancer Inform Special Articles Informatics solutions to early diagnosis of cancer in primary care are increasingly prevalent, but it is not clear whether existing and planned standards and regulations sufficiently address patients' safety nor whether these standards are fit for purpose. We use a patient safety perspective to reflect on the development of a computerized cancer risk assessment tool embedded within a UK primary care electronic health record system. METHODS: We developed a computerized version of the CAncer Prevention in ExetER studies risk assessment tool, in compliance with the European Union's Medical Device Regulations. The process of building this tool afforded an opportunity to reflect on clinical concerns and whether current regulations for medical devices are fit for purpose. We identified concerns for patient safety and developed nine practical recommendations to mitigate these concerns. RESULTS: We noted that medical device regulations (1) were initially created for hardware devices rather than software, (2) offer one-shot approval rather than supporting iterative innovation and learning, (3) are biased toward loss-transfer approaches that attempt to manage the fallout of harm instead of mitigating hazards becoming harmful, and (4) are biased toward known hazards, despite unknown hazards being an expected consequence of health care as a complex adaptive system. Our nine recommendations focus on embedding less-reductionist and stronger system perspectives into regulations and standards. CONCLUSION: Our intention is to share our experience to support research-led collaborative development of health informatics solutions in cancer. We argue that regulations in the European Union do not sufficiently address the complexity of healthcare information systems with consequences for patient safety. Future standards and regulations should continue to follow a system-based approach to risk, safety, and accident avoidance. Wolters Kluwer Health 2021-04-02 /pmc/articles/PMC8140795/ /pubmed/33797951 http://dx.doi.org/10.1200/CCI.20.00148 Text en © 2021 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Special Articles
McInerney, Ciarán D.
Scott, Beverly C.
Johnson, Owen A.
Are Regulations Safe? Reflections From Developing a Digital Cancer Decision-Support Tool
title Are Regulations Safe? Reflections From Developing a Digital Cancer Decision-Support Tool
title_full Are Regulations Safe? Reflections From Developing a Digital Cancer Decision-Support Tool
title_fullStr Are Regulations Safe? Reflections From Developing a Digital Cancer Decision-Support Tool
title_full_unstemmed Are Regulations Safe? Reflections From Developing a Digital Cancer Decision-Support Tool
title_short Are Regulations Safe? Reflections From Developing a Digital Cancer Decision-Support Tool
title_sort are regulations safe? reflections from developing a digital cancer decision-support tool
topic Special Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140795/
https://www.ncbi.nlm.nih.gov/pubmed/33797951
http://dx.doi.org/10.1200/CCI.20.00148
work_keys_str_mv AT mcinerneyciarand areregulationssafereflectionsfromdevelopingadigitalcancerdecisionsupporttool
AT scottbeverlyc areregulationssafereflectionsfromdevelopingadigitalcancerdecisionsupporttool
AT johnsonowena areregulationssafereflectionsfromdevelopingadigitalcancerdecisionsupporttool